All prescription products require a medical consultation with a licensed provider, either asynchronously or synchronously, who will determine if a prescription is appropriate
Metformin has been a first-line diabetes treatment for over 60 years with an excellent safety profile across billions of doses
It summarizes published pharmacology, clinical-trial dosing context, and common protocol planning patterns
FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L
It comes in the form of an injection and mimics the hormone GLP-1, making people feel fuller and less hungry
Learn how to assess safety while purchasing compounded semaglutide, and the benefits, risks, costs, and considerations of using compounded semaglutide
